Rankings

Brazil:

Brazil:
Ranked Departments:
Ranked Individuals:
Contributions and articles
Provided by Kestener Vieira Torronteguy Spegiorin Advogados
- Articles, Press releases, highlights

Brazil: Contentious
Overview
Provided by Kestener Vieira Torronteguy Spegiorin Advogados
Firm Overview:
Kestener & Vieira Advogados (KVLAW) is a Brazilian law firm composed of partners with vast experience and knowledge in their practice areas. Technology and innovation are elements that are part of KVLAW’s essence and the expertise of its professionals, combined with a young, talented and innovative team, has led to high productivity since the firm’s inception. KVLAW has extensive knowledge in highly regulated fields, such as life sciences, food and drug, internet and information technology, cyber law, e-commerce, data privacy, startups and innovation enabling KVLAW to offer full and excellent legal services to clients active in these industries. Established on a solid foundation of ethics, transparency, and integrity, KVLAW’s mission is to establish long-term, unique and trusting relationships with its clients. The firm places a high value on understanding the needs and particularities of each client in order to provide customised and exceptional service.
Data Protection & Privacy:
KVLAW advises clients in the life sciences, food, technology and automotive sectors on all aspects of data protection and privacy, from the structuring and implementation of data protection compliance programs, and the elaboration of policies, procedures, training, and contracts, to impact assessments, incident analysis, and support in responses to data subjects and performance with regulatory bodies.
Corporate, M&A & Contracts:
KVLAW’s corporate team provides legal counsel for all types of corporate structure in their day-to-day activities, the firm plays an active role in many deals in Brazil assisting in a wide range of projects related to mergers and acquisitions transactions, complex deals involving private equity and venture capital, purchase and sale of corporate holdings, assets and goodwill, planning and implementation of corporate reorganisations, corporate governance matters, finance transactions, such as offshore loans for working capital of companies.
Life Sciences:
The KVLAW team is a pioneer in the health, biotechnology, drug, food, agriculture and biodiversity areas, representing clients in all related sectors: pharmaceutical ingredients, drugs, biotechnology products, fresh and processed foods, food supplements, beverages, cosmetic and hygiene products, medical devices, sanitising products, animal health and crop farming products, including pesticides and fertilisers. The firm also advises many of the corresponding industry associations.
Litigation & Alternative Dispute Resolution:
KVLAW’s civil litigation practice represents clients in disputes involving corporate, contract, civil liability and family and estate law. KVLAW also offers extensive advisory services, assurance and technical support to represent foreign and domestic clients’ interests in institutional or ‘ad-hoc’ arbitral proceedings in Brazil or abroad. The firm also holds a consumer law and product liability practice area, providing services on consumer law issues and representing clients in court cases and at the National Consumer Protection System hearings.
Public Law:
KVLAW's Bidding Tenders and Public Contracts team supports clients involved in government tenders, contracts and agreements with the Public Administration, as well as Public Private Partnerships (PPPs).
Startups & Innovation:
KVLAW provides a broad range of services focused on the development of innovative projects and in the creation of a safe and stimulating environment for Startups, individually or in cooperation with accelerators, venture capital funds, angel investors, regulatory agencies and other companies. Providing services with the involvement of many practice areas such as IP, tax, labour, compliance, consumer, civil, corporate, regulatory, etc.
Tax:
The KVLAW team advises major Brazilian and foreign companies, as well as individuals, on a wide range of tax issues, offering consultation and litigation services on administrative and judicial matters. The tax area professionals have a solid academic and professional background, both in Brazil and abroad, specialising in direct and indirect taxes, social security, customs, international taxation, Universal Basis Taxation rules, Transfer Pricing and thin capitalisation issues.
International Work:
KVLAW's attorneys have long-time experience in working in cross-border matters as well as dealing with foreign companies doing business in Brazil.
Languages:
English, French, Spanish, Portuguese.
Kestener Vieira Torronteguy Spegiorin Advogados | Brazil: Contentious

Brazil: Industries & Sectors
Overview
Provided by Kestener Vieira Torronteguy Spegiorin Advogados
Firm Overview:
Kestener Vieira Torronteguy Spegiorin Advogados is a Brazilian law firm composed of partners with vast experience and knowledge in their practice areas. Technology and innovation are elements that are part of KVTS' essence and the expertise of its professionals, combined with a young, talented and innovative team, has led to high productivity since the firm’s inception. KTVS has extensive knowledge in highly regulated fields, such as life sciences, food and drug, internet and information technology, cyber law, e-commerce, data privacy, startups and innovation enabling KVTS to offer full and excellent legal services to clients active in these industries. Established on a solid foundation of ethics, transparency, and integrity, KVTS' mission is to establish long-term, unique and trusting relationships with its clients. The firm places a high value on understanding the needs and particularities of each client in order to provide customised and exceptional service.
Data Protection and Privacy:
KVTS advises clients in the life scienes, food, technology and automotive sectors on all aspects of data protection and privacy, from the structuring and implementation of data protection compliance programs, and the elaboration of policies, procedures, training, and contracts, to impact assessments, incident analysis, and support in responses to data subjects and performance with regulatory bodies.
Corporate, M&A & Contracts:
KVTS' corporate team provides legal counsel for all types of corporate structure in their day-to-day activities, the firm plays an active role in many deals in Brazil assisting in a wide range of projects related to mergers and acquisitions transactions, complex deals involving private equity and venture capital, purchase and sale of corporate holdings, assets and goodwill, planning and implementation of corporate reorganisations, corporate governance matters, finance transactions, such as offshore loans for working capital of companies.
Life Sciences:
The KVTS team is a pioneer in the health, biotechnology, drug, food, agriculture and biodiversity areas, representing clients in all related sectors: pharmaceutical ingredients, drugs, biotechnology products, fresh and processed foods, food supplements, beverages, cosmetic and hygiene products, medical devices, sanitising products, animal health and crop farming products, including pesticides and fertilisers. The firm also advises many of the corresponding industry associations.
Litigation & Alternative Dispute Resolution:
KVTS' civil litigation practice represents clients in disputes involving corporate, contract, civil liability and family and estate law. KVTS also offers extensive advisory services, assurance and technical support to represent foreign and domestic clients’ interests in institutional or ‘ad-hoc’ arbitral proceedings in Brazil or abroad. The firm also holds a consumer law and product liability practice area, providing services on consumer law issues and representing clients in court cases and at the National Consumer Protection System hearings.
Public Law:
KVTS' Bidding Tenders and Public Contracts team supports clients involved in government tenders, contracts and agreements with the Public Administration, as well as Public Private Partnerships (PPPs).
Startups & Innovation:
KVTS provides a broad range of services focused on the development of innovative projects and in the creation of a safe and stimulating environment for Startups, individually or in cooperation with accelerators, venture capital funds, angel investors, regulatory agencies and other companies. Providing services with the involvement of many practice areas such as IP, tax, labour, compliance, consumer, civil, corporate, regulatory, etc.
Tax:
The KVTS team advises major Brazilian and foreign companies, as well as individuals, on a wide range of tax issues, offering consultation and litigation services on administrative and judicial matters. The tax area professionals have a solid academic and professional background, both in Brazil and abroad, specialising in direct and indirect taxes, social security, customs, international taxation, Universal Basis Taxation rules, Transfer Pricing and thin capitalisation issues.
International Work:
KVTS' attorneys have long-time experience in working in cross-border matters as well as dealing with foreign companies doing business in Brazil.
Languages:
English, French, Spanish, Portuguese.
Ranked Offices
Provided by Kestener Vieira Torronteguy Spegiorin Advogados
Brazil - Head office
Sao Paulo
Rua Funchal, 418 - Vila Olímpia , São Paulo - SP, Sao Paulo, Brazil, 04551-060, São Paulo - SP
Ranked Departments
Ranked Individuals
Articles, highlights and press releases
24 items provided by Kestener Vieira Torronteguy Spegiorin Advogados
E‑NatJus for “rare diseases” and a “technical cooperation agreement” (MoH, CNJ and AGU)
Ministry of Health, CNJ and AGU: creation of an e‑NatJus unit for “rare diseases” and a “technical cooperation agreement” on the judicialization of medicines
Advertising of Medicines and the Supreme Court
Advertising of Medicines: The Debate Continues at the Supreme Court Amid New Attempts by ANVISA to Reverse the Current Outcome
Advertising of Medicines and Food at the Brazilian Supreme Court
The regulated sector has been talking extensively about the public hearing. However, this is not the only way to participate strategically in the debate—and it may not even be the most effective one.
MAPA Changes Rules for Administrative Proceedings and Procedures for Entering into TACs
In Sep 2025, the Ministry of Agriculture and Livestock published Ordinance No. 1,364/2025 to regulate the execution of Conduct Adjustment Agreements (“TACs”) within the context of agricultural and livestock inspection, in addition to establishing specific procedures for administrative proceedings.
A New Business Landscape Emerges in the Sector Regulated by Anvisa
The arrival of Anvisa’s new Director‑President (economist Leandro Pinheiro Safatle) and the inauguration of the Agency’s new Board of Directors in September 2025 mark the beginning of a significant institutional shift with direct impact on the regulatory and economic environment of the sector.
High‑Exposure Recalls – The New Perception of Reputational Risk and the Shift in Regulatory Approach
Product recall actions involving medicines and food—whether voluntary or mandated by the regulator—have come to be handled with greater rigor by Anvisa, MAPA, and consumer‑protection authorities.
The Cost of Neglecting the Legal Risk Behind a “Simple” Response to ANVISA or MAPA Official Letters
Official letters of this nature actually represent the beginning of a technical‑legal dialogue with significant potential to generate relevant consequences for a company’s operations and/or its rights.
Medicinal Cannabis: New ANVISA Resolutions Redefine the Brazilian Pharmaceutical Market
The new resolutions published in 2026 by the Brazilian Health Regulatory Agency (“Anvisa”) mark a turning point in the regulation of medicinal cannabis in Brazil.
Overview of Access, Litigation, and the Supply of Drugs
Overview of Access, Litigation, and the Supply of Medicines: the Importance of the Industry Analyzing and Monitoring Qualified Data on Judicial Demands
New National System for Phytosanitary Certification of Origin (Sinfito)
New National System for Phytosanitary Certification of Origin (Sinfito): MAPA publishes SDA/MAPA Ordinance No. 1,578/2026 with significant rules on phytosanitary certification and various other provisions applicable to the sector
Sancionada Lei de Pesquisa Clínica
A Lei nº 14.874/2024, que regula a pesquisa com seres humanos e cria o Sistema Nacional de Ética em Pesquisa, foi sancionada com vetos presidenciais, visando proteger direitos de vulneráveis e garantir a continuidade do fornecimento pós-estudo de medicamentos.
Desenvolvimento da LGPD no Brasil: Resolução ANPD nº 15/24
A Resolução nº 15/2024 da ANPD regulamenta a comunicação de incidentes de segurança, exigindo notificação à ANPD em 3 dias úteis e detalhando os requisitos de conteúdo e procedimentos, visando proteger dados pessoais no Brasil.
Eleição de Foro: novas regras impactam os contratos e a propositura de ações judiciais
A Lei nº 14.879/2024 altera o CPC para restringir a eleição de foro nos contratos, exigindo relação com domicílio, residência ou local da obrigação.
Consulta Pública 1.249/2024 classifica risco de atividades econômicas sob Vigilância Sanitária
Em 13.5.2024, Anvisa lançou Consulta Pública sobre identificação e classificação do risco de atividades econômicas sob Vigilância Sanitária.
Publicado Decreto que regulamenta a inspeção e a fiscalização dos produtos destinados à alimentação
Foi publicado hoje o Decreto Federal nº 12.031/2024, regulamentando inspeção e fiscalização de produtos para alimentação animal, abordando aspectos como registro, condições dos estabelecimentos e penalidades. Entrará em vigor em 08/07/2024.
Mudança na regra de Eleição de Foro prevista no Código de Processo Civil
O Senado aprovou o PL 1803/2023, limitando a eleição de foro em contratos escritos ao domicílio de uma das partes ou local da obrigação, visando evitar o "fórum shopping". Aguarda sanção presidencial para entrar em vigor.
Assembleias Gerais e o regime de invalidades segundo o STJ
A Assembleia Geral das sociedades por ações pode ter deliberações inválidas por irregularidades. O STJ decidiu que a Lei das S.A. prevalece em relações intrassocietárias, enquanto o Código Civil se aplica a terceiros. Esta decisão visa unificar a interpretação legal e trazer mais segurança jurídica.
Certificado fitossanitário eletrônico (ePhyto) é implementado pelo MAPA
O MAPA lançou o ePhyto, um certificado fitossanitário eletrônico que facilita a troca de informações entre países importadores e exportadores, reduzindo custos, burocracia, fraudes e prazos, promovendo maior segurança e transparência.
Senado Federal aprova Projeto de Lei de Pesquisa Clínica
Após mais de sete anos de tramitação, o PL nº 6007/2023, que regula a pesquisa com seres humanos e cria o Sistema Nacional de Ética em Pesquisa Clínica, foi aprovado pelo Senado em 23.4.2024 e segue para sanção presidencial.
Marco Legal da Pesquisa Clínica: apresentamos os principais pontos do PL
A Câmara dos Deputados aprovou o PL nº 7082/2017, que regula pesquisas clínicas com humanos no Brasil, proporcionando segurança jurídica e alterando regras atuais. O projeto retorna ao Senado para revisão.
Anvisa lança programa de apoio a startups para inovação de medicamentos
O Edital de Chamamento Público nº 1 apoia startups brasileiras no desenvolvimento de fitoterápicos, medicamentos sintéticos e biológicos, oferecendo suporte regulatório. Propostas devem ser enviadas até 7.5.2024.
Produtos de uso veterinário suspeitos e irregulares no mercado: ações do MAPA e da Polícia Federal
O aumento de produtos veterinários irregulares viola leis, distorce a concorrência e ameaça a saúde animal. Em março, a PF e o MAPA realizaram buscas em Rondônia e Mato Grosso para combater essa prática.
Política Nacional de Cibersegurança - Decreto 11.856/2023
O Decreto nº 11.856/2023 institui a Política Nacional de Cibersegurança e cria o Comitê Nacional de Cibersegurança no Brasil, com o objetivo de fortalecer a proteção contra ataques cibernéticos e promover cooperação internacional.
Adesão da Anvisa ao Programa de Operador Econômico autorizado (OEA) e a simplificação aduaneira
A Anvisa aderiu ao Programa OEA-Integrado, visando eficiência e segurança nas importações de produtos sob vigilância sanitária. Empresas certificadas terão benefícios como redução de fiscalização e priorização nas análises.
E‑NatJus for “rare diseases” and a “technical cooperation agreement” (MoH, CNJ and AGU)
Ministry of Health, CNJ and AGU: creation of an e‑NatJus unit for “rare diseases” and a “technical cooperation agreement” on the judicialization of medicines
Advertising of Medicines and the Supreme Court
Advertising of Medicines: The Debate Continues at the Supreme Court Amid New Attempts by ANVISA to Reverse the Current Outcome
Advertising of Medicines and Food at the Brazilian Supreme Court
The regulated sector has been talking extensively about the public hearing. However, this is not the only way to participate strategically in the debate—and it may not even be the most effective one.
MAPA Changes Rules for Administrative Proceedings and Procedures for Entering into TACs
In Sep 2025, the Ministry of Agriculture and Livestock published Ordinance No. 1,364/2025 to regulate the execution of Conduct Adjustment Agreements (“TACs”) within the context of agricultural and livestock inspection, in addition to establishing specific procedures for administrative proceedings.
A New Business Landscape Emerges in the Sector Regulated by Anvisa
The arrival of Anvisa’s new Director‑President (economist Leandro Pinheiro Safatle) and the inauguration of the Agency’s new Board of Directors in September 2025 mark the beginning of a significant institutional shift with direct impact on the regulatory and economic environment of the sector.
High‑Exposure Recalls – The New Perception of Reputational Risk and the Shift in Regulatory Approach
Product recall actions involving medicines and food—whether voluntary or mandated by the regulator—have come to be handled with greater rigor by Anvisa, MAPA, and consumer‑protection authorities.
The Cost of Neglecting the Legal Risk Behind a “Simple” Response to ANVISA or MAPA Official Letters
Official letters of this nature actually represent the beginning of a technical‑legal dialogue with significant potential to generate relevant consequences for a company’s operations and/or its rights.
Medicinal Cannabis: New ANVISA Resolutions Redefine the Brazilian Pharmaceutical Market
The new resolutions published in 2026 by the Brazilian Health Regulatory Agency (“Anvisa”) mark a turning point in the regulation of medicinal cannabis in Brazil.
Overview of Access, Litigation, and the Supply of Drugs
Overview of Access, Litigation, and the Supply of Medicines: the Importance of the Industry Analyzing and Monitoring Qualified Data on Judicial Demands
New National System for Phytosanitary Certification of Origin (Sinfito)
New National System for Phytosanitary Certification of Origin (Sinfito): MAPA publishes SDA/MAPA Ordinance No. 1,578/2026 with significant rules on phytosanitary certification and various other provisions applicable to the sector
Sancionada Lei de Pesquisa Clínica
A Lei nº 14.874/2024, que regula a pesquisa com seres humanos e cria o Sistema Nacional de Ética em Pesquisa, foi sancionada com vetos presidenciais, visando proteger direitos de vulneráveis e garantir a continuidade do fornecimento pós-estudo de medicamentos.
Desenvolvimento da LGPD no Brasil: Resolução ANPD nº 15/24
A Resolução nº 15/2024 da ANPD regulamenta a comunicação de incidentes de segurança, exigindo notificação à ANPD em 3 dias úteis e detalhando os requisitos de conteúdo e procedimentos, visando proteger dados pessoais no Brasil.
Eleição de Foro: novas regras impactam os contratos e a propositura de ações judiciais
A Lei nº 14.879/2024 altera o CPC para restringir a eleição de foro nos contratos, exigindo relação com domicílio, residência ou local da obrigação.
Consulta Pública 1.249/2024 classifica risco de atividades econômicas sob Vigilância Sanitária
Em 13.5.2024, Anvisa lançou Consulta Pública sobre identificação e classificação do risco de atividades econômicas sob Vigilância Sanitária.
Publicado Decreto que regulamenta a inspeção e a fiscalização dos produtos destinados à alimentação
Foi publicado hoje o Decreto Federal nº 12.031/2024, regulamentando inspeção e fiscalização de produtos para alimentação animal, abordando aspectos como registro, condições dos estabelecimentos e penalidades. Entrará em vigor em 08/07/2024.
Mudança na regra de Eleição de Foro prevista no Código de Processo Civil
O Senado aprovou o PL 1803/2023, limitando a eleição de foro em contratos escritos ao domicílio de uma das partes ou local da obrigação, visando evitar o "fórum shopping". Aguarda sanção presidencial para entrar em vigor.
Assembleias Gerais e o regime de invalidades segundo o STJ
A Assembleia Geral das sociedades por ações pode ter deliberações inválidas por irregularidades. O STJ decidiu que a Lei das S.A. prevalece em relações intrassocietárias, enquanto o Código Civil se aplica a terceiros. Esta decisão visa unificar a interpretação legal e trazer mais segurança jurídica.
Certificado fitossanitário eletrônico (ePhyto) é implementado pelo MAPA
O MAPA lançou o ePhyto, um certificado fitossanitário eletrônico que facilita a troca de informações entre países importadores e exportadores, reduzindo custos, burocracia, fraudes e prazos, promovendo maior segurança e transparência.
Senado Federal aprova Projeto de Lei de Pesquisa Clínica
Após mais de sete anos de tramitação, o PL nº 6007/2023, que regula a pesquisa com seres humanos e cria o Sistema Nacional de Ética em Pesquisa Clínica, foi aprovado pelo Senado em 23.4.2024 e segue para sanção presidencial.
Marco Legal da Pesquisa Clínica: apresentamos os principais pontos do PL
A Câmara dos Deputados aprovou o PL nº 7082/2017, que regula pesquisas clínicas com humanos no Brasil, proporcionando segurança jurídica e alterando regras atuais. O projeto retorna ao Senado para revisão.
Anvisa lança programa de apoio a startups para inovação de medicamentos
O Edital de Chamamento Público nº 1 apoia startups brasileiras no desenvolvimento de fitoterápicos, medicamentos sintéticos e biológicos, oferecendo suporte regulatório. Propostas devem ser enviadas até 7.5.2024.
Produtos de uso veterinário suspeitos e irregulares no mercado: ações do MAPA e da Polícia Federal
O aumento de produtos veterinários irregulares viola leis, distorce a concorrência e ameaça a saúde animal. Em março, a PF e o MAPA realizaram buscas em Rondônia e Mato Grosso para combater essa prática.
Política Nacional de Cibersegurança - Decreto 11.856/2023
O Decreto nº 11.856/2023 institui a Política Nacional de Cibersegurança e cria o Comitê Nacional de Cibersegurança no Brasil, com o objetivo de fortalecer a proteção contra ataques cibernéticos e promover cooperação internacional.
Adesão da Anvisa ao Programa de Operador Econômico autorizado (OEA) e a simplificação aduaneira
A Anvisa aderiu ao Programa OEA-Integrado, visando eficiência e segurança nas importações de produtos sob vigilância sanitária. Empresas certificadas terão benefícios como redução de fiscalização e priorização nas análises.
